Will new acquisitions rake in revenues for Acropetal Tech?

D Ravi Kumar, Chairman & Managing Director, Acropetal Technologies Ltd, in an interview on CNBC-TV18 said in FY11, the company clocked Rs 28 crore profit on a consolidated basis. He also added that they planned on maintaining their CAGR of 37% and that new acquisitions would add to the company's topline.

Below is a verbatim transcript of his interview with CNBC-TV18's Udayan Mukherjee and Mitali Mukherjee. For complete details watch the accompanying video.

Q: Can you start by telling us what you expect to achieve by the end of FY12 in terms of revenues and profits?

A: For Acropetal it is a very proud moment today. We have opened on the BSE stock exchange and we have listed on a very positive note. The shares are listing at a very high price.

Coming to the revenues, they will be inline with our past performance of CAGR of 37%. For 2009-2010 we already made a profit of Rs 28 crore, with Rs 148 crore turnover. Acropetal believes that CAGR will be maintained and we will take it forward with new acquisitions which we are planning which will add to the topline as well.

Q: Can you just repeat that profit figure – Rs 28 crore because our estimate is that you have done about Rs 18 crore in the nine month period for FY11 and profits?

A: It is Rs 28 crore on a consolidated basis.

Q: What is it that you hope to do on an earnings per share and in profits in FY12?

A: Earning per share it will be more or less the same as to what we have done in our past performance. I am not able to comment on it but it will be maintained or will be more or less the same on the earnings per share as well.

Does CNBC-TV18's Udayan Mukherjee agree? Click Here